GlobeNewswire Inc.··Allarity TherapeuticsAllarity Therapeutics Secures Patent Allowance for Stenoparib Companion Diagnostic
Allarity Therapeutics received USPTO notice of allowance for stenoparib DRP® companion diagnostic patent, providing exclusivity through 2039.
ALLRPhase 2 clinical trialstenoparib